Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 30, 2022

Primary Completion Date

October 1, 2024

Study Completion Date

March 1, 2025

Conditions
Lung CancerNSCLC, Stage IIINSCLC Stage IVLung Cancer Stage IVMutationCancerCancer, Lung
Interventions
DRUG

sotorasib

single group, all patients receive sotorasib

Trial Locations (1)

3004

RECRUITING

Vestre Viken Health Trust, Drammen

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Oslo University Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Karolinska University Hospital

OTHER

collaborator

University Hospital of North Norway

OTHER

collaborator

Haukeland University Hospital

OTHER

collaborator

St. Olavs Hospital

OTHER

lead

Vestre Viken Hospital Trust

OTHER